Quantexa Named a Luminary in Everest Groups Innovation Watch Report
LONDON, July 02, 2025 (GLOBE NEWSWIRE) -- Quantexa, a global leader in…
eClerx Named a Major Contender in Everest Groups Marketing Services PEAK Matrix 2025
NEW YORK--(BUSINESS WIRE)--#CX--eClerx Services Ltd (ECLERX.NS), a leading productized services company, today…
Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal…